NCI researchers discovered a molecule called Beta-defensin 2 that activates an immune response
On Oct. 31, 2002, National Cancer Institute (NCI) researchers announced they had discovered that a molecule best known…
Diagnostics | Infectious Disease | Polio | Vaccine | WHO
The European Region was certified polio-free
On Jun. 21, 2002, all 53 Member States in the World Health Organization (WHO) European Region were certified…
Diphtheria and tetanus toxoids and acellular pertussis vaccine (Daptacel by Aventis Pasteur) was licensed
On May 14, 2002, the Food and Drug Administration (FDA) approved for use an additional combined diphtheria and…
GlaxoSmithKline announced the company would no longer manufacture or distribute its Lyme disease vaccine
On Feb. 25, 2002, GlaxoSmithKline announced that the company would no longer manufacture or distribute its Lyme disease…
Rotary International launched a second fundraising campaign to eradicate polio
In 2002, the Rotary International launched a Polio Eradication Fundraising Campaign with a fundraising target of $80 million…
Institute of Medicine called for creation of a national vaccine authority
On Nov. 5, 2001, following the events of September 11, the Institute of Medicine again called for creation…
The CDC learned of a domestic terrorism attack via anthrax sent through the mail
On Sept. 11, 2001, the U.S. Centers for Disease Control and Prevention (CDC) learned of a domestic terrorism…
The Bill and Melinda Gates Foundation earmarked $70 million to develop and produce meningitis vaccines
On May 29, 2001, the Bill & Melinda Gates Foundation announced today a global health grant of $70…
A combined hepatitis A inactivated and hepatitis B (recombinant) vaccine was licensed
On May 11, 2001, the Food and Drug Administration (FDA) licensed a combined hepatitis A and B vaccine…
The CDC responded to the World Trade Center and bioterrorism anthrax attacks
In 2001, the U.S. Centers for Disease Control and Prevention (CDC) responded to the World Trade Center and…
Peter St. George-Hyslop developed a vaccine that prevented Alzheimer’s disease in mice
On Dec. 21, 2000, Dr. Peter St George-Hyslop developed a vaccine that prevented Alzheimer’s disease in mice. The…
Biotechnology | Infectious Disease | Polio | Vaccine | WHO
The Western Pacific Region of the world was certified as polio-free
On Oct. 29, 2000, the Regional Commission for the Certification of Poliomyelitis Eradication certified that the Western Pacific…
NIAID created global network to advance development of HIV vaccines
On May 25, 2000, the National Institute of Allergy and Infectious Diseases (NIAID) announced funding of nine U.S….
A 7-valent pneumococcal conjugate vaccine was licensed
On Feb. 17, 2000, the Food and Drug Administration (FDA) announced it it had licensed a 13-valent pneumococcal…
Biotechnology | CDC | Infectious Disease | Polio | Vaccine
The use of Oral polio vaccine (OPV) was discontinued in the U.S.
In 2000, the use of Oral polio vaccine (OPV) was discontinued in the U.S. to eliminate the risk…
Measles was declared no longer endemic in the U.S.
In 2000, measles was declared no longer endemic in the U.S. following eradication campaigns that began in 1967….
Diphtheria and tetanus toxoids and acellular pertussis vaccine was licensed
On Dec. 9, 1999, the diphtheria and tetanus toxoids and acellular pertussis vaccine (Tripedia by Connaught) was licensed….
The Bill & Melinda Gates Foundation pledged $750 million to establish the Global Fund for Children’s Vaccines
On Nov. 23, 1999, the Bill & Melinda Gates Foundation pledged a gift of $750 million over five…
ACIP voted to withdraw their recommendation for rotavirus vaccine
On Oct. 22, 1999, the Advisory Committee on Immunization Practices (ACIP), after a review of scientific data from…
Wyeth Lederle Vaccines voluntarily withdrew Rotashield from the market
On Oct. 15, 1999, Wyeth-Lederle Vaccines announced that it was withdrawing the Rotashield vaccine from the market and…
The CDC identified and responded to West Nile Virus in New York City
In August 1999, an outbreak of encephalitis caused by West Nile virus (WNV) was detected in New York…
Biotechnology | CDC | Infectious Disease | Polio | Vaccine
ACIP recommended exclusive use of inactivated poliovirus vaccine (IPV) for infants and children
On Jun. 17, 1999, the U.S. Centers for Disease Control and Prevention’s (CDC) Immunization Practices Advisory Committee (ACIP)…
The Dale and Betty Bumpers Vaccine Research Center was established
On Jun. 9, 1999, the Dale and Betty Bumpers Vaccine Research Center (VRC) was established at the National…
A pandemic planning framework was published by the World Health Organization
In April 1999, a pandemic planning framework was published by the World Health Organization (WHO) that emphasized the…
Biotechnology | CDC | FDA | Infectious Disease | Vaccine
ACIP recommended DTaP vaccines for all five doses in the vaccination schedule
On Jan. 15. 1999, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
A meningococcal group C conjugate vaccine was introduced into the routine schedule in the UK
In 1999, a meningococcal group C conjugate vaccine was introduced into the routine schedule in the U.K. for…
The CDC launched the National Pharmaceutical Stockpile for emergency health security
In 1999, the U.S. Centers for Disease Control and Prevention (CDC) launched the National Pharmaceutical Stockpile, now the…
The CDC’s Laboratory Response Network was established
In 1999, the U.S. Centers for Disease Control and Prevention (CDC) established the Laboratory Response Network (LRN). The…
Lyme Disease Vaccine (Recombinant OspA) was licensed
On Dec. 21, 1998, the Lyme Disease Vaccine (Recombinant OspA), (LYMErix by SmithKline Beecham) was licensed for use…
Rotavirus vaccine, live, oral, tetravalent was licensed
On Aug. 31, 1998, Rotashield (Wyeth Laboratories, Marietta, Pennsylvania) was licensed by the U.S. Food and Drug Administration…